Sharon Shacham

2018

In 2018, Sharon Shacham earned a total compensation of $2.1M as President and Chief Scientific Officer at Karyopharm Therapeutics, a 16% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$183,063
Option Awards$1,444,660
Salary$450,000
Other$11,660
Total$2,089,383

Shacham received $1.4M in option awards, accounting for 69% of the total pay in 2018.

Shacham also received $183.1K in non-equity incentive plan, $450K in salary and $11.7K in other compensation.

Rankings

In 2018, Sharon Shacham's compensation ranked 5,502nd out of 14,244 executives tracked by ExecPay. In other words, Shacham earned more than 61.4% of executives.

ClassificationRankingPercentile
All
5,502
out of 14,244
61st
Division
Manufacturing
2,077
out of 5,762
64th
Major group
Chemicals And Allied Products
766
out of 2,125
64th
Industry group
Drugs
641
out of 1,814
65th
Industry
Pharmaceutical Preparations
494
out of 1,388
64th
Source: SEC filing on April 19, 2019.

Shacham's colleagues

We found four more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2018.

2018

Anand Varadan

Karyopharm Therapeutics

Executive Vice President, Chief Commercial Officer

2018

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2018

Christopher Primiano

Karyopharm Therapeutics

General Counsel

2018

Michael MSM

Karyopharm Therapeutics

Chief Financial Officer

News

In-depth

You may also like